BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study
What is the purpose of this trial?PURPOSE OF STUDY Different people have different biomarkers (chemical "markers" in the blood that may be related to your reaction to study drugs). If researchers know about your biomarkers before you receive treatment, they may be able to prescribe a treatment that is better suited to your body's specific needs. The goal of this clinical research study is to learn if a drug or drug combinations based on your biomarkers can help to control NSCLC. The safety of these drug combinations will also be studied.
- 18 and older
- MD Anderson Cancer Center
- Last Updated:
- Study HIC#:
Clinicaltrials.gov ID: Yale0186992